---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-22-045420"
form_type: "8-K"
ticker: "RBOT"
cik: "0001812173"
company_name: "Vicarious Surgical Inc."
filed_at: "2022-08-08T23:59:59+00:00"
generated_at: "2026-06-24T02:59:31.406130+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Vicarious Surgical Q2 2022: adjusted net loss $19.1M, operating expenses up 189% YoY

## Summary
- Operating expenses of $19.1M for Q2 2022, up from $6.6M in Q2 2021; R&D $10.1M, G&A $7.8M, S&M $1.3M.
- Adjusted net loss of $19.1M ($0.16 loss per share) vs $6.6M ($0.08 loss per share) prior year.
- GAAP net loss of $1.5M ($0.01 loss per share) vs $6.6M ($0.08 loss per share) prior year.
- Cash burn rate for Q2 2022 was $15.7M; no revenue reported (pre-commercial stage).
- Beta 2 system development ongoing; announced Center of Excellence partnerships with UH Ventures and HCA Healthcare.

## SEC filing metadata
- accession: 0001213900-22-045420
- form_type: 8-K
- ticker: RBOT
- cik: 0001812173
- company_name: Vicarious Surgical Inc.
- filed_at: 2022-08-08T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1812173/000121390022045420/0001213900-22-045420-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1812173/000121390022045420/ea163898-8k_vicarious.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-22-045420
- JSON: https://secwatch.observer/filing/0001213900-22-045420.json
- Plain text: https://secwatch.observer/filing/0001213900-22-045420.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.